Skip to main content
. 2015 Oct 20;103:530–538. doi: 10.1016/j.ejmech.2015.08.044

Table 3.

In vivo antimalarial Activity against P. berghei (ANKA).

Dose (mg/kg/day × 4) Route % Reduction parasitaemia P. berghei ANKA GFP Survival (days)
20 50 ipa 12 6
Chloroquine 10 ip 99.97 20
Control 7
a

ip: intraperitoneal route of administration.